Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.

Saurabh KediaSaransh JainSandeep GoyalSawan BopannaDawesh P YadavVikas SachdevPeush SahniSujoy PalNihar Ranjan DashGovind MakhariaSimon P L TravisVineet Ahuja

Published in: Digestive diseases and sciences (2018)

FCP could differentiate ASC from mild to moderate patients with UC, but requires validation before clinical use.

Keyphrases

early onset
drug induced
disease activity
rheumatoid arthritis
nlrp inflammasome
systemic lupus erythematosus
human health